phenytoin and tat 59
phenytoin has been researched along with tat 59 in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Fleisher, D; Flynn, G; Forsberg, M; Heimbach, T; Leppänen, J; Li, LY; Matsunaga, Y; Oh, DM; Savolainen, J | 1 |
| Fleisher, D; Garcia, G; Heimbach, T; Li, LY; Oh, DM; Rodríguez-Hornedo, N | 1 |
Other Studies
2 other study(ies) available for phenytoin and tat 59
| Article | Year |
|---|---|
Absorption rate limit considerations for oral phosphate prodrugs.
Topics: Administration, Oral; Algorithms; Animals; Area Under Curve; Biological Transport, Active; Caco-2 Cells; Catechols; Chemical Phenomena; Chemistry, Physical; Humans; Hydrocortisone; Hydrogen-Ion Concentration; In Vitro Techniques; Intestinal Absorption; Intestinal Mucosa; Jejunum; Male; Nitriles; Perfusion; Permeability; Phenytoin; Prodrugs; Rats; Rats, Wistar; Tamoxifen | 2003 |
Enzyme-mediated precipitation of parent drugs from their phosphate prodrugs.
Topics: Alkaline Phosphatase; Caco-2 Cells; Chemical Precipitation; Chromatography, High Pressure Liquid; Crystallization; Drug Stability; Estramustine; Humans; Mass Spectrometry; Organophosphates; Phenytoin; Prodrugs; Solubility; Tamoxifen | 2003 |